Ozempic (Semaglutide): Uses, Dosing, Results & Side Effects

What is Ozempic?

Ozempic is the brand name under which Novo Nordisk markets semaglutide for the treatment of type 2 diabetes. It comes as a once-weekly subcutaneous injection delivered through a multi-dose, prefilled pen that you inject under the skin of the abdomen, thigh, or upper arm. Because it's taken just once a week, it's far more convenient than the daily insulin or multiple-times-daily pills many people with diabetes have historically relied on.

Chemically, semaglutide is a GLP-1 receptor agonist — a molecule engineered to mimic the natural gut hormone glucagon-like peptide-1. If you're new to the class, our explainer on what GLP-1 is and how it works covers the biology in plain English. In short, Ozempic prompts the pancreas to release insulin when blood sugar is high, suppresses the hormone glucagon, slows how quickly the stomach empties, and signals fullness to the brain. The natural hormone lasts only a minute or two; semaglutide is redesigned to last about a week, which is what makes once-weekly dosing possible.

What is Ozempic approved for?

Ozempic carries several FDA-approved indications, and it's worth being precise about them because the gap between what it's approved for and how it's popularly used is large.

• Type 2 diabetes. Its core approval is to improve blood sugar control (glycemic control) in adults with type 2 diabetes, used alongside diet and exercise.
• Cardiovascular risk reduction. Ozempic is approved to reduce the risk of major cardiovascular events — including heart attack and stroke — in adults who have both type 2 diabetes and established cardiovascular disease.
• Kidney protection. Semaglutide also has a kidney-related indication, reflecting trial evidence that it can slow the progression of kidney disease in people with type 2 diabetes.

Notice what's missing from that list: weight loss. Despite Ozempic's fame as a weight-loss drug, weight loss is not an approved indication. When a clinician prescribes Ozempic specifically to help someone lose weight, that's an off-label use — legal and common, but it affects insurance coverage and is something to discuss honestly with your prescriber.

Ozempic dosing schedule

Ozempic is always started low and increased gradually — a process called titration — to give your digestive system time to adjust and to minimize nausea. The typical schedule looks like this:

• 0.25 mg once weekly for 4 weeks. This is a starter dose, not a therapeutic one. It does little for blood sugar; its only job is to ease you onto the medication.
• 0.5 mg once weekly. After the first month, the dose steps up to 0.5 mg, the first dose intended to actually treat blood sugar.
• 1 mg once weekly. If more glucose control is needed after at least 4 weeks at 0.5 mg, the dose can be increased to 1 mg.
• 2 mg once weekly. The maximum Ozempic dose, used when additional control is required based on response and tolerability.

Each step generally requires at least four weeks at the prior dose before moving up. The injection is taken on the same day each week, at any time of day, with or without food. If you miss a dose, the timing of how to catch up depends on how many days have passed — your pharmacist or prescriber can advise.

How well does Ozempic work?

For its primary job — lowering blood sugar — Ozempic is highly effective. Across the SUSTAIN clinical trial program, semaglutide lowered A1c (a three-month average of blood sugar) by roughly 1.5 to 2 percentage points, often outperforming other diabetes drugs it was compared against. For context, that's a large reduction in a measure where even half a point is clinically meaningful.

Weight loss came along as a powerful secondary effect. In the SUSTAIN trials, participants typically lost on the order of 9 to 14 pounds depending on dose — enough to attract enormous attention, but generally less than the dedicated, higher-dose weight-loss version. That's the key nuance many people miss: Ozempic does cause weight loss, but the formulation specifically designed and dosed for it is Wegovy.

Ozempic vs. Wegovy vs. Rybelsus

One of the biggest sources of confusion is that the same active molecule — semaglutide — is sold under three different brand names, each tuned for a different purpose. Sorting them out:

• Ozempic — the once-weekly injection for type 2 diabetes and cardiovascular risk reduction. Maximum dose 2 mg.
• Wegovy — the once-weekly injection approved specifically for chronic weight management, at a higher maximum dose of 2.4 mg. Same drug, different indication and top dose.
• Rybelsus — the oral semaglutide tablet, taken daily, approved for type 2 diabetes. Same molecule, pill form.

So if you've seen all three names and assumed they were different drugs, they're not — they're semaglutide in different doses, routes, and approved uses. If weight loss is your goal, our GLP-1 weight-loss guide walks through which products are actually indicated for it and why that distinction matters for both safety and cost. And for a side-by-side of every GLP-1 option, see our medications comparison.

Ozempic side effects

The most common side effects of Ozempic are gastrointestinal: nausea, vomiting, diarrhea, and constipation. These are usually worst when you first start or step up a dose and tend to ease over time — which is exactly why the titration schedule exists. Most people find them manageable; for some, they're the reason they stop.

Beyond the everyday GI effects, Ozempic shares the serious warnings common to its entire drug class:

• Thyroid tumor boxed warning. Ozempic carries a boxed warning about the risk of thyroid C-cell tumors, based on animal studies. It is contraindicated in anyone with a personal or family history of medullary thyroid carcinoma (MTC) or the genetic syndrome MEN 2.
• Pancreatitis. Inflammation of the pancreas has been reported; persistent severe abdominal pain warrants stopping the drug and seeking care.
• Other risks include gallbladder problems, kidney issues (often linked to dehydration from vomiting or diarrhea), and the potential for low blood sugar when combined with insulin or sulfonylureas.

This is an overview, not the full safety picture. For a deeper look at what's common, what's serious, and practical ways to reduce nausea, read our dedicated GLP-1 side effects guide.

What does Ozempic cost?

Like most brand-name GLP-1 drugs, Ozempic carries a high list price, though what you actually pay depends heavily on insurance and where you fill it. Coverage for diabetes is generally better than coverage for off-label weight-loss use, which is one more reason the approved-indication distinction matters in practice. We break down pricing, insurance, and savings options in our GLP-1 cost and insurance guide.

The bottom line

Ozempic is semaglutide, a once-weekly GLP-1 injection from Novo Nordisk that's genuinely effective at lowering blood sugar, reducing cardiovascular risk in people with diabetes and heart disease, and protecting the kidneys — with substantial weight loss as a bonus. But it's a prescription medication with a boxed warning and real contraindications, and it is not the product approved for weight loss. If weight management is the goal, the right semaglutide is Wegovy, and the decision belongs with a clinician who knows your full history.

Frequently asked questions